College of Medicine and Public Health

Activities

Activities per year 1974 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2023

• 262 Invited talk
• 165 Other
• 150 Oral presentation
• 25 Membership of committee
• 93 More
  • 20 Participating in a conference, workshop, ...
  • 17 Organising a conference, workshop, ...
  • 14 Editorial work
  • 12 Publication Peer-review
  • 12 Membership of network
  • 6 Visiting an external academic institution
  • 5 Consultancy
  • 4 Membership of board
  • 2 Examination
  • 1 Membership of council

Activities per year

Search results

• Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial). Valgimigli M, Tricoci P, Huang Z, Aylward PE, Armstrong PW, Van de Werf F, Leonardi S, White HD, Widimsky P, Harrington RA, Cequier A, Chen E, Lokhnygina Y, Wallentin L, Strony J, Mahaffey KW, Moliterno DJ. Am J Cardiol. 2014 Sep 1;114(5):665-73. doi: 10.1016/j.amjcard.2014.05.054. Epub 2014 Jun 18. PMID: 25129064 Clinical Trial.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial. Held C, Tricoci P, Huang Z, Van de Werf F, White HD, Armstrong PW, Ambrosio G, Aylward PE, Moliterno DJ, Wallentin L, Chen E, Erkan A, Jiang L, Strony J, Harrington RA, Mahaffey KW. Eur Heart J Acute Cardiovasc Care. 2014 Sep;3(3):246-56. doi: 10.1177/2048872614527838. Epub 2014 Mar 13. PMID: 24627331 Clinical Trial.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial. Tricoci P, Lokhnygina Y, Huang Z, Van de Werf F, Cornel JH, Chen E, Wallentin L, Held C, Aylward PE, Moliterno DJ, Jennings LK, White HD, Armstrong PW, Harrington RA, Strony J, Mahaffey KW. Am Heart J. 2014 Dec;168(6):869-77.e1. doi: 10.1016/j.ahj.2014.09.002. Epub 2014 Sep 16. PMID: 25458650 Clinical Trial.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Coronary artery disease: Darapladib fails to improve the STABILITY of CAD. Roberts A. Nat Rev Cardiol. 2014 Jun;11(6):310. doi: 10.1038/nrcardio.2014.50. Epub 2014 Apr 15. PMID: 24736761

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER). Jones WS, Tricoci P, Huang Z, Moliterno DJ, Harrington RA, Sinnaeve PR, Strony J, Van de Werf F, White HD, Held C, Armstrong PW, Aylward PE, Chen E, Patel MR, Mahaffey KW. Am Heart J. 2014 Oct;168(4):588-96. doi: 10.1016/j.ahj.2014.06.017. Epub 2014 Jul 4. PMID: 25262270 Clinical Trial.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• New antithrombotics for secondary prevention of acute coronary syndrome. Goto S, Tomita A. Clin Cardiol. 2014 Mar;37(3):178-87. doi: 10.1002/clc.22233. Epub 2014 Jan 22. PMID: 24452610 Review.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Darapladib for preventing ischemic events in stable coronary heart disease. STABILITY Investigators, White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim HS, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler ER 3rd, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse HF, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. N Engl J Med. 2014 May 1;370(18):1702-11. doi: 10.1056/NEJMoa1315878. Epub 2014 Mar 30. PMID: 24678955 Clinical Trial.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy. Storey RF, Kotha J, Smyth SS, Moliterno DJ, Rorick TL, Moccetti T, Valgimigli M, Dery JP, Cornel JH, Thomas GS, Huber K, Harrington RA, Hord E, Judge HM, Chen E, Strony J, Mahaffey KW, Tricoci P, Becker RC, Jennings LK. Thromb Haemost. 2014 May 5;111(5):883-91. doi: 10.1160/TH13-07-0624. Epub 2014 Jan 9. PMID: 24402559 Clinical Trial.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial). Mahaffey KW, Huang Z, Wallentin L, Storey RF, Jennings LK, Tricoci P, White HD, Armstrong PW, Aylward PE, Moliterno DJ, Van de Werf F, Chen E, Leonardi S, Rorick T, Held C, Strony J, Harrington RA. Am J Cardiol. 2014 Mar 15;113(6):936-44. doi: 10.1016/j.amjcard.2013.11.052. Epub 2013 Dec 25. PMID: 24444781 Clinical Trial.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Triazole derivatives: a series of Darapladib analogues as orally active Lp-PLA2 inhibitors. Wang K, Xu W, Zhang W, Mo M, Wang Y, Shen J. Bioorg Med Chem Lett. 2013 May 15;23(10):2897-901. doi: 10.1016/j.bmcl.2013.03.062. Epub 2013 Mar 26. PMID: 23575276

  Erin Morton (Other)

  2013

  Activity: Other activity types › Other

• Skills for Collaboration, Behaviour Change & Managing Complexity: Building the Aged Care Workforce Capacity in Complex Care Coordination

  Sharon Lawn (Participant)

  2013

  Activity: Other activity types › Other

• Analytical evaluation of the GeneXpert® CT/NG, the first genetic point of care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis

  Sepehr Tabrizi (Participant), Magnus Unemo (Participant), Daniel Golparian (Participant), Jimmy Twin (Participant), Athena Limnios (Participant), Monica Lahra (Participant), R. Guy (Participant) & Mark Shephard (Participant)

  14 Jul 2013 → 17 Jul 2013

  Activity: Other activity types › Other

• Air Embolus During Clavicle Internal Fixation with a Plate. Australian Orthopaedic Association Newsletter. 2 March 1999

  Greg Bain (Participant), Kevin Eng (Participant) & Matthias Zumstein (Participant)

  2013

  Activity: Other activity types › Other

• Volunteer Musician: Heart Foundation Fundraiser

  Charlotte EJ Downes (Participant)

  Oct 2012

  Activity: Other activity types › Other

• Vorapaxar expands antiplatelet options. Which patients may benefit from thrombin receptor antagonism? Duerschmied D, Bode C. Hamostaseologie. 2012;32(3):221-7. doi: 10.5482/HAMO-12-05-0006. Epub 2012 Jul 10. PMID: 22777302

  Erin Morton (Other)

  2012

  Activity: Other activity types › Other

• Vorapaxar expands antiplatelet options. Duerschmied D, Bode C. Hamostaseologie. 2012;32(3):221-227. doi: 10.5482/HAMO-12-05-0006. Epub 2017 Dec 28. PMID: 29589363 English.

  Erin Morton (Other)

  2012

  Activity: Other activity types › Other

• Utility of Lp-PLA2 in lipid-lowering therapy. Racherla S, Arora R. Am J Ther. 2012 Mar;19(2):115-20. doi: 10.1097/MJT.0b013e3181e70d32. PMID: 20634673 Review.

  Erin Morton (Other)

  2012

  Activity: Other activity types › Other

• Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW; TRACER Investigators. N Engl J Med. 2012 Jan 5;366(1):20-33. doi: 10.1056/NEJMoa1109719. Epub 2011 Nov 13. PMID: 22077816 Clinical Trial.

  Erin Morton (Other)

  2012

  Activity: Other activity types › Other

• Graduate Of Australian Institute of Company Directors

  Emma Kennedy (Participant)

  2011

  Activity: Other activity types › Other

• Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease. White H, Held C, Stewart R, Watson D, Harrington R, Budaj A, Steg PG, Cannon CP, Krug-Gourley S, Wittes J, Trivedi T, Tarka E, Wallentin L. Am Heart J. 2010 Oct;160(4):655-61. doi: 10.1016/j.ahj.2010.07.006. PMID: 20934559 Clinical Trial.

  Erin Morton (Other)

  2010

  Activity: Other activity types › Other

• Extracellular phospholipases in atherosclerosis. Karabina SA, Gora S, Atout R, Ninio E. Biochimie. 2010 Jun;92(6):594-600. doi: 10.1016/j.biochi.2010.02.002. Epub 2010 Feb 12. PMID: 20153800 Review.

  Erin Morton (Other)

  2010

  Activity: Other activity types › Other

• Equity of bowel cancer screening: An epidemiological and qualitative Study. Final Report. 2010.

  Paul Ward (Other), Sara Javanparast (Other), Michelle Ah Matt (Other), Stephen R. Cole (Other), Paul Aylward (Other), Tiffany Gill (Other), Angelita Martini (Other), Carlene Wilson (Other), Genevieve Baratiny (Other), Gary Misan (Other), George Tsourtos (Other), Graeme P. Young AM FTSE FAHMS AGAF (Other) & Jodie Waite (Other)

  2010

  Activity: Other activity types › Other

• Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease. Riley RF, Corson MA. IDrugs. 2009 Oct;12(10):648-55. PMID: 19790016 Review.

  Erin Morton (Other)

  2009

  Activity: Other activity types › Other

• Standards for Point-of-Care Pathology Testing for health checks conducted by WorkSafe Victoria

  Mark Shephard (Participant)

  2009

  Activity: Other activity types › Other

• The Healthiest Country by 2020: Making Smoking History

  Sharon Lawn (Participant)

  2008

  Activity: Other activity types › Other

• An Analysis of Training and Information Options to Support Chronic Disease Prevention and Self-Management in Primary Health Care

  Malcolm Battersby (Participant), Sharon Lawn (Participant), Leanne Wells (Participant), Steve Morris (Participant), Trisha Wong (Participant), Helen Lindner (Participant), Rebecca Mathews (Participant), Richard Reed (Participant) & John Litt (Participant)

  2008

  Activity: Other activity types › Other

• Proximal Biceps Tendon Anatomy. ISAKOS 2007, Biceps Tendon Monograph

  Greg Bain (Participant)

  2007

  Activity: Other activity types › Other

• Undergraduate Nursing Curricula and the Future of Nurses’ Involvement in Chronic Condition Self-Management

  Jill Beattie (Participant), Alison Martin (Participant), Marie Heartfield (Participant), Ellie Lawrence-Wood (Participant), Malcolm Battersby (Participant), Cassandra Hood (Participant), Richard Reed (Participant), Karen Grimmer-Somers (Participant), Gary Misan (Participant) & Sharon Lawn (Participant)

  2007

  Activity: Other activity types › Other

• The Colon Cancer Family Registry, an international resource for studying the genetic and molecular epidemiology of colorectal cancer. Gastrointestinal Cancer Update. 2006;46:14-20.

  M.A. Jenkins (Other), F. Macrae (Other), J. Young (Other), M. Barker (Other), B. Leggett (Other), J. Goldblatt (Other), J. Kirk (Other), K. Tucker (Other), Graeme K. Suthers (Other), Graeme P. Young AM FTSE FAHMS AGAF (Other), S. Parry (Other), J. Arnold (Other), Ingrid Winship (Other), J. Maskiell (Other), Graham G. Giles (Other), Jeremy Jass (Other) & J. Hopper (Other)

  2006

  Activity: Other activity types › Other

• Pharmacogenomics, Australian Pharmaceutical Formulary

  C. A. Haddy (Participant), Ross McKinnon (Participant), Michael Sorich (Participant) & M Ward (Participant)

  2006 → …

  Activity: Other activity types › Other

• Clinical Advisor, Beyond Blue

  Michael Baigent (Other)

  2006 → 2011

  Activity: Other activity types › Other

• GEMP Chronic Condition Self-Management Curriculum

  Rene Pols (Participant), Malcolm Battersby (Participant), Sharon Lawn (Participant) & Mignon Markwick (Participant)

  2005

  Activity: Other activity types › Other

• Population screening for colorectal cancer. In Clinical Practice Guidelines for the prevention, early detection and management of colorectal cancer. Chapter 3. NHMRC, Canberra, 2nd edition, 2005, 32-45.

  Graeme P. Young AM FTSE FAHMS AGAF (Other)

  2005

  Activity: Other activity types › Other

• Clinical Practice Guidelines for the prevention, early detection and management of colorectal cancer. 2005.

  Graeme P. Young AM FTSE FAHMS AGAF (Other)

  2005

  Activity: Other activity types › Other

• Submission to Australian Government Productivity Commission based on proposals included in The Position Paper from the Australia's Health Workforce Study

  Sarah Blunden (Participant), Malcolm Battersby (Participant), Rene Pols (Participant), Sharon Lawn (Participant), Anthea Williams (Participant) & David Agnew (Participant)

  2005

  Activity: Other activity types › Other

• Differential induction of micronuclei in peripheral lymphocytes and exfoliated urothelial cells of workers exposed to 4,4’-methylenebis-(2-chloroaniline)(MOCA) and bitumen fumes. Murray, E.B. and Edwards, J.W. (2005). Reviews on Environmental Health 20(3): 163-176. 10.1515/REVEH.2005.20.3.163

  Erin Morton (Other)

  2005

  Activity: Other activity types › Other

• Point-of-Care in Aboriginal Hands - A working model for the early detection, prevention and management of chronic disease in rural and remote Australian Aboriginal Communities

  Mark Shephard (Participant) & Beryl Mazzachi (Participant)

  2003

  Activity: Other activity types › Other

• Point-of-Care Testing for diabetes management in rural communities - Australian Council of Community Nursing Services

  Mark Shephard (Participant)

  2003

  Activity: Other activity types › Other

• Point-of-Care Testing and it's application in Aboriginal Hands - Aboriginal Health Council of SA

  Mark Shephard (Participant)

  2003

  Activity: Other activity types › Other

• Is it time to consider the sociology of nicotine addiction? Smoking and Social Disadvantage

  Sharon Lawn (Participant)

  2003

  Activity: Other activity types › Other

• The 'QAAMS" program for Urine ACR Testing on the DCA 2000 - Education, Training and Quality Assurance for Aboriginal Health Workers

  Mark Shephard (Participant)

  2003

  Activity: Other activity types › Other

• Screening for colorectal cancer: Total colonoscopic investigation with colonoscopy or double contrast barium enema? Seminars in Colon and Rectal Surgery. 2000, 11(1), 9-16.

  Peter Bampton (Other) & Graeme P. Young AM FTSE FAHMS AGAF (Other)

  2000

  Activity: Other activity types › Other

• Shoulder Anatomy. The Royal Australian College of Practitioners.

  Greg Bain (Participant) & Janak Mehta (Participant)

  2000

  Activity: Other activity types › Other

• Micronuclei in peripheral lymphocytes and exfoliated urothelial cells of workers exposed to 4,4’-methylenebis-(2-chloroaniline)(MOCA). Murray, E.B. and Edwards, J.W. (1999). Mutation Research 446: 175-180

  Erin Morton (Other)

  1999

  Activity: Other activity types › Other

• Wrist. The Royal Australian College of General Practitioners. September 1999.

  Greg Bain (Participant) & Rik Verhellen (Participant)

  1999

  Activity: Other activity types › Other

• Complex fractures of the hand. The Royal Australian College of General Practitioners. 313, Feb/Mar 1998

  Greg Bain (Participant) & Janak Mehta (Participant)

  1998

  Activity: Other activity types › Other

• Fellow of the Royal Australian College of General Practitioners

  Emma Kennedy (Participant)

  1998

  Activity: Other activity types › Other

• Diet and large bowel cancer prevention. Cancer Forum, 1995, 19, 160-163.

  G. McIntosh (Other) & Graeme P. Young AM FTSE FAHMS AGAF (Other)

  1995

  Activity: Other activity types › Other

• Fermentation of polysaccharides and colonic health. 45th Australian Cereal Chemistry Conference Proceedings, RACI, 1995, pp21-25.

  Graeme P. Young AM FTSE FAHMS AGAF (Other)

  1995

  Activity: Other activity types › Other

• Community screening for colorectal cancer. Diagnostic Oncology, 1995, 4, 65-72.

  Graeme P. Young AM FTSE FAHMS AGAF (Other) & D. James B. St. John (Other)

  1995

  Activity: Other activity types › Other